Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Oesophageal Squamous Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07090499
What this trial is testing

Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Who this might be right for
Advanced/Metastatic Solid TumorsBladder CancerUrothelial Carcinoma+10 more
Pfizer 540
Early research (Phase 1)Study completedNCT03708328
What this trial is testing

A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors

Who this might be right for
Solid TumorsMetastatic MelanomaNon-small Cell Lung Cancer (NSCLC)+2 more
Hoffmann-La Roche 134
Large-scale testing (Phase 3)Active Not RecruitingNCT05043688
What this trial is testing

Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.

Who this might be right for
Resectable Esophageal Squamous Cell Carcinoma
Zhigang Li 426
Testing effectiveness (Phase 2)UnknownNCT01232374
What this trial is testing

Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma
Biotech Pharmaceutical Co., Ltd. 144
Testing effectiveness (Phase 2)Looking for participantsNCT06489197
What this trial is testing

AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients

Who this might be right for
ESCCAdvanced Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06908382
What this trial is testing

Neoadjuvant QL1706 Therapy for ESCC

Who this might be right for
Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Shandong Provincial Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT07039162
What this trial is testing

Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Locally Advanced Unresectable Esophageal Cancer
Ming-Yu Lien 45
Early research (Phase 1)Study completedNCT02964455
What this trial is testing

Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 12
Testing effectiveness (Phase 2)Looking for participantsNCT05937438
What this trial is testing

Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

Who this might be right for
Esophageal Carcinoma
Anhui Provincial Hospital 70
Not applicableActive Not RecruitingNCT06504615
What this trial is testing

Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France

Who this might be right for
Gastric AdenocarcinomaGastro-esophageal Junction AdenocarcinomaEsophageal Adenocarcinoma (EAC)+1 more
Bristol-Myers Squibb 208
Early research (Phase 1)UnknownNCT05164848
What this trial is testing

JMT101 Combined With Afatinib in Patients With Advanced Esophageal Squamous Cell Carcinoma After Standard Therapy

Who this might be right for
Esophageal Squamous Carcinoma
Peking University 50
Testing effectiveness (Phase 2)Looking for participantsNCT07811752
What this trial is testing

Sacituzumab Govitecan Combined With Tislelizumab for Locally Advanced/Metastatic Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital 28
Large-scale testing (Phase 3)Looking for participantsNCT06676449
What this trial is testing

TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC

Who this might be right for
Esophageal CarcinomaRadiotherapyImmunotherapy
Fudan University 432
Testing effectiveness (Phase 2)UnknownNCT05221658
What this trial is testing

A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC

Who this might be right for
ESCC or Esophageal Adenosquamous Carcinoma
Shanghai Henlius Biotech 60
Testing effectiveness (Phase 2)Looking for participantsNCT07730021
What this trial is testing

ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Astellas Pharma Global Development, Inc. 392
Early research (Phase 1)Study completedNCT00019110
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

Who this might be right for
Anal CancerCervical CancerEsophageal Cancer+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT05866510
What this trial is testing

Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
Peking University 47
Post-approval studies (Phase 4)Ended earlyNCT02721550
What this trial is testing

A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC

Who this might be right for
Esophageal Neoplasms
Shandong Cancer Hospital and Institute 2
Testing effectiveness (Phase 2)Looking for participantsNCT06885814
What this trial is testing

Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Nanfang Hospital, Southern Medical University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06746961
What this trial is testing

Efficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcinoma After Disease Progression on ICIs Therapy

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
The First Affiliated Hospital of Zhengzhou University 49
Next Page